Online Exclusives

PolyPhotonix’s Noctura 400 Sleep Mask Helps Combat Diabetic Retinopathy

The Noctura 400 delivers a precise dose of light therapy during a patient’s normal hours of sleep.

The World Health Organisation regards diabetes as a global epidemic. The current global population of diabetics is estimated at 400 million and is set to grow to 500 million by 2020. In the UK alone, there are currently 4 million diabetics and this is expected to grow to 5.5 million by 2020. Currently more than 280,000 people a year are diagnosed with diabetes.   One of the impacts of diabetes is diabetic retinopathy (DR), a disease caused by diabetes. DR is one of the most common causes of blin...

Become an Industry Insider and get FREE 24/7 access to this story and all of Ink World magazine.


Already a subscriber? Sign in

Add us as a preferred source on Google

Get the latest Ink World magazine news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Ink World magazine Newsletters